TRAX — First Tracks Biotherapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2091349 ·
Last close
$17.06
Market Cap
$595.09M
52W High
$26.80
52W Low
$14.79
ADV30
455,878
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -52,811,000 | -50,484,000 | 290,576,000 | 248,469,000 | 33,112,000 |
| Mar 2025 | 0 | — | -51,280,000 | -47,196,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-77,567,000
Investing CF
$49,830,000
Financing CF
$13,567,000
CapEx
$-52,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.81
As of
2026-05-20
Balance + Analyst (yfinance extras)
Retained Earnings
—
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
7
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 0 | -181,101,000 | -163,705,000 | 441,891,000 | 50,295,000 | — | -125,806,000 |
| Dec 2023 | 0 | -118,461,000 | -106,150,000 | 444,109,000 | 34,260,000 | — | -93,004,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-3.18
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VREOF | Vireo Growth Inc. | $598.52M | $0.44 | — |
| ZVRA | ZEVRA THERAPEUTICS, INC. | $610.07M | $10.32 | — |
| GYRE | GYRE THERAPEUTICS, INC. | $576.35M | $5.94 | — |
| ARVN | ARVINAS, INC. | $575.53M | $8.92 | — |
| ALT | Altimmune, Inc. | $569.81M | $2.93 | — |
News headlines (Yahoo Finance, 1h cache)
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences
2026-05-21 20:15 · Yahoo
How The Grupo Traxión (BMV:TRAXION A) Story Is Shifting With Cautious New Analyst Targets
2026-05-15 14:18 · Yahoo
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
2026-05-14 20:15 · Yahoo
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
2026-05-12 20:15 · Yahoo
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?
2026-05-10 23:13 · Yahoo
First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases
2026-04-20 13:15 · Yahoo
AnaptysBio Board Approves Spin-Off of First Tracks Bio, Repurchase of $100 Million Shares
2026-03-27 13:58 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.